By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlobeImmune, Inc. 

1450 Infinite Drive

Louisville  Colorado  80027  U.S.A.
Phone: 303-625-2700 Fax: 303-625-2710


Company News
GlobeImmune (GBIM) Announces Third Quarter 2015 Results And Corporate Highlight 11/13/2015 10:54:26 AM
GlobeImmune (GBIM) Announces Second Quarter 2015 Results And Corporate Highlights 8/14/2015 9:31:16 AM
Struggling GlobeImmune (GBIM) Taps Financial Adviser to Assist in "Strategic Alternatives" 8/13/2015 7:23:16 AM
Celgene (CELG) Exercises Early Option To Exclusively License GI-6207, A Novel Cancer Immunotherapy 8/4/2015 9:48:42 AM
Struggling GlobeImmune (GBIM) Slashing Majority of Workforce Following Failed HBV Trial 6/10/2015 6:21:29 AM
GlobeImmune, Inc. (GBIM) Announces Top Line Results From GS-4774 Phase II Trial In Virally-Suppressed Chronic HBV Patients 5/27/2015 6:10:00 AM
Gilead (GILD), GlobeImmune (GBIM)'s Hep B Drug Flunks Phase II Study 5/27/2015 6:09:10 AM
GlobeImmune, Inc. (GBIM) Announces First Quarter 2015 Results And Corporate Highlights 5/14/2015 12:19:32 PM
GlobeImmune, Inc. (GBIM) Announces Opening Of Randomized Phase 2 Chordoma Trial At National Cancer Institute 4/22/2015 10:42:17 AM
GlobeImmune, Inc. (GBIM) Announces Program Updates And Financial Results For Full Year 2014 3/17/2015 10:40:43 AM